Alphamab Oncology (FRA:3NK)
1.170
+0.040 (3.54%)
At close: Nov 27, 2025
137.80% (1Y)
| Market Cap | 1.12B |
| Revenue (ttm) | 93.42M |
| Net Income (ttm) | 27.67M |
| Shares Out | n/a |
| EPS (ttm) | 0.03 |
| PE Ratio | 40.42 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 65 |
| Open | 1.170 |
| Previous Close | 1.130 |
| Day's Range | 1.170 - 1.170 |
| 52-Week Range | 0.354 - 1.680 |
| Beta | n/a |
| RSI | 48.74 |
| Earnings Date | Nov 28, 2025 |